Search Tag: breast cancer screening
2025 14 Apr
The integration of artificial intelligence into mammographic screening workflows has the potential to enhance diagnostic accuracy, streamline clinical operations and optimise resource allocation. However, the dynamic nature of AI models, which allows them to evolve through frequent software updates, introduces new challenges in clinical governance....Read more
2025 28 Mar
Breast cancer remains the most common malignancy among women in Europe and continues to be a leading cause of cancer-related deaths. While population-based mammographic screening programmes are in place across all European countries, significant variability exists in how these programmes are structured, implemented and attended. One major challenge...Read more
2025 24 Feb
The integration of artificial intelligence into mammography screening has the potential to revolutionise breast cancer detection by improving efficiency and diagnostic accuracy. The Mammography Screening with Artificial Intelligence (MASAI) trial, a large-scale, randomised controlled study, assessed the impact of AI-supported screening compared...Read more
2025 18 Feb
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer, accounting for 5% to 15% of all cases. Unlike invasive ductal carcinoma (IDC), ILC has an infiltrative growth pattern that makes detection challenging with traditional screening methods. Its lack of cell cohesion and tendency to grow in single-file...Read more
2025 08 Feb
Breast cancer screening is a crucial tool in early detection, enabling timely intervention and improving survival rates. While women at high risk due to genetic mutations or previous chest irradiation are recommended for regular MRI screening alongside mammography, those with an intermediate risk often receive only mammography. This group, which...Read more
2024 07 Oct
Mammography plays a pivotal role in early detection of breast cancer. With the emergence of artificial intelligence (AI), there is increasing interest in its potential to enhance the accuracy and efficiency of mammography screening. Recent research has evaluated whether AI systems can replace human readers in double-reading workflows, which are...Read more
2024 23 Sep
Breast cancer remains the most commonly diagnosed cancer among women worldwide, and its early detection is critical for improving treatment outcomes and reducing mortality. Traditional mammography, while effective, is limited by its two-dimensional (2D) nature, often leading to false positives, false negatives, and a high recall rate due to overlapping...Read more
2024 01 Sep
Breast cancer remains a significant health concern, particularly for women with dense breast tissue. High mammographic density not only elevates the risk of breast cancer but also complicates the detection process, often leading to missed diagnoses. Mammography, the standard screening tool, has reduced sensitivity in women with dense breasts, which...Read more
2024 28 May
Mammography is the main method for breast cancer screening but is less effective for individuals with dense breast tissue, who have a higher risk of cancer. Contrast-enhanced MRI is more sensitive but expensive and time-consuming. An abbreviated MRI (AB-MR) protocol shows promise in maintaining sensitivity while reducing time and cost. Studies...Read more
2024 23 May
The first few waves of COVID-19 slowed life across the United States, affecting everything from attending school to eating out for dinner and going on vacation. Segments of health care were also affected: Services that were not considered immediately crucial to fighting the virus were slowed or stopped during the pandemic’s first wave. ...Read more
2024 30 Apr
As leaders in women’s health, we know the importance of routine screenings and preventive care, and we’re pleased the United States Preventive Services Task Force has finalized its recommendation that average-risk women begin breast cancer screening at age 40. We hope this decision will raise awareness about early detection and highlight the critical...Read more
2024 30 Apr
The United States Preventive Services Task Force (USPSTF) has updated its recommendations for breast cancer screening, suggesting that women should begin regular mammograms at the age of 40 rather than waiting until 50 as previously advised. This decision, published in JAMA , was reached by one of the foremost independent organisations setting...Read more
2024 21 Feb
Breast cancer remains a significant health concern, standing as the second leading cause of cancer-related deaths among women in the United States. Despite advancements in detection and treatment, the impact of breast cancer continues to be substantial, with projections indicating over 353,500 new cases and approximately 43,700 deaths expected...Read more
2023 29 May
The U.S. Preventive Services Task Force (USPSTF) recently reviewed the evidence and effectiveness of breast cancer screening. They recommend that all women begin screening for breast cancer at age 40 and screen every other year until age 74. In 2016 the task force recommended that biennial mammograms start at age 50 and the decision for women...Read more
2022 18 Nov
As 3D mammography has become more widely available, figures show that an increasing number of women are opting for this screening test over the standard 2D mammography. Reports have indicated that this screening test leads to reduced number of false positive results, and has been found to identify more cancers in women with dense breasts. ...Read more
2022 06 Nov
The Austrian Health Insurance Fund (ÖGK) and the Medical Association are considering changing the present breast cancer screening program to a risk-based breast cancer screening. The goal of running an age-based screening programme is to diagnose cancer as early as possible in order to reduce the chances of missing a diagnosis. It helps to reduce...Read more
2021 16 Oct
The U.S. FDA recently granted PMA approval to Delphinus Medical Technologies’ SoftVue™ 3D Whole Breast Ultrasound Tomography System. This system is intended to supplement digital mammography for cancer screening women with dense breasts. About 40% of U.S. women have dense breast tissue, a risk factor for breast cancer. This risk is three-to-six times...Read more
2020 30 Oct
At Hologic , we understand the importance of reducing imaging interpretation time, especially during a time when you might be facing with a backlog in breast cancer screening appointments. We are therefore very pleased to introduce 3DQuorum breast imaging technology. Designed to expedite Hologic Clarity™ HD high-resolution 3D...Read more
2020 30 Sep
October is Breast Cancer Awareness Month. This is an annual campaign to increase awareness of breast cancer. The goal is to show every woman that her life is important and to ensure that every woman has access to education, screening, treatment, support and hope. According to the American Cancer Society , there are more than 270,000 new cases...Read more
2019 18 Dec
Researchers in New Zealand are combining machine learning (ML) and standard imaging to improve both diagnosis and treatment of breast cancer. You might also like: RSNA 2019: Biennial Mammography Screening Yields More Advanced-Stage Cancers The Auckland Bioengineering Institute, Science and technology, Health and medicine Researchers...Read more
2019 24 Sep
A recent study in Radiology showed that selective mammography can help identify breast cancer for men with a high-risk. The rarity of breast cancer in men has led to little research on the outcomes in this cohort despite the high rates of mortality. Out of the 2670 cases of invasive breast cancer estimated to be diagnosed in 2019, the American Cancer...Read more
2019 11 Jul
Affidea and ScreenPoint Medical announced a strategic partnership to streamline and improve the clinical performance of screening mammography and drive the earlier detection of breast cancer. The partnership will leverage Affidea’s growing footprint in the European breast imaging marketplace and will provide a unique opportunity for ScreenPoint...Read more
2019 10 Apr
“Mammography does more harm than good” sums up countless headlines seen in many medical journals, books, and other published articles (print and online). A flood of damaging reports amplified perceived risk of “over-diagnosis” and over-treatment. Study after flawed study — like a house of cards — touted mammography’s alleged harms and costs. This...Read more
2019 13 Mar
Breast cancer screening remains controversial, despite strong evidence of its benefits, including a recent study showing a 47% reduction in risk of death among Swedish women who participated in screening compared with those who did not. In addition, U.S. National Cancer Institute (NCI) data demonstrate that breast cancer mortality has fallen 43% since...Read more
2018 27 Nov
In a study presented during the annual meeting of the Radiological Society of North America (RSNA) in Chicago, researchers found that overweight women are at increased risk of missing to discover a breast tumor until it has grown too large. The results show that women with a higher measure of body fat based on height and weight (BMI) might need to...Read more
2018 20 Nov
Women aged 75 and older should continue to perform mammography screening as a high occurrence of breast cancer was found among this older age group in a new study that will be presented next week at the annual meeting of the Radiological Society of North America (RSNA). There has been controversy in recent years on what the cut-off age should be...Read more
2018 26 Sep
Black women are more likely to be diagnosed at later stages of breast cancer partly due to barriers to timely screening mammography, resulting in poorer mortality and survival outcomes. The use of patient navigators – individuals who provide guidance to patients to help overcome various barriers to care – may reduce breast cancer disparities. ...Read more
2018 29 May
Based on stage at diagnosis of breast cancer, the greatest mortality reduction is achieved with mammography utilisation starting at the age of 40. This is the main finding of a study that compared estimated 5-year mortalities of patients diagnosed with breast cancer based on stage at diagnosis and national screening mammography guideline categorisation....Read more
2018 20 Mar
A new study examining the effectiveness of screening mammography reveals these findings: the rate of breast cancer detection is higher (up 19.3 percent) in women ages 40–49 compared to the screening population ages 50 and above. The additional cancers detected translate to an overall 1.5% increase in callbacks and 0.1% in increased biopsies. The new...Read more